ML Laboratories

ML Laboratories was a prominent British pharmaceutical company focused on the development of innovative drug delivery systems and treatments for respiratory and renal conditions. The company's most significant commercial success was the development of icodextrin, a glucose polymer used in the peritoneal dialysis solution Extraneal, which was licensed globally to Baxter Healthcare. Additionally, through its subsidiary Innovata Biomed, ML Laboratories developed advanced respiratory delivery devices, including the Clickhaler and Duohaler dry powder inhalers. In 2005, ML Laboratories merged with Quadrant Technologies to form Vectura Group, a leading player in the inhaled airways disease market. The company's legacy continues through its foundational contributions to dialysis treatment and pulmonary drug delivery platforms.